This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1985.
Company Filing History:
Years Active: 1985
Title: Joseph W Parton: Innovator in Angiogenesis Inhibition
Introduction
Joseph W Parton is a notable inventor based in Greenfield, IN (US). He has made significant contributions to the field of biochemistry, particularly in the development of angiogenesis inhibitors. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Joseph W Parton holds a patent for "Ascorbic acid ethers in angiogene - Ethers of ascorbic and isoascorbic acid and ketals and acetals thereof, angiogenesis inhibitors." This patent highlights his research into the potential therapeutic uses of ascorbic acid derivatives in inhibiting angiogenesis, which is crucial for controlling tumor growth and other pathological conditions.
Career Highlights
Parton is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and research. His role at the company has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Joseph has collaborated with esteemed colleagues such as Jesse R Bewley and Gary A Koppel. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.
Conclusion
Joseph W Parton exemplifies the spirit of innovation in the pharmaceutical industry through his research and patent contributions. His work continues to influence the development of effective medical treatments.